Calcified Tissue International

, Volume 77, Issue 1, pp 1–8 | Cite as

Reduced Relative Risk of Fractures Among Users of Lithium



Lithium has been shown to inhibit bone resorption and to interact with Wnt signaling, potentially pointing to bone anabolic properties. We, therefore, studied the effects of lithium on fracture risk using a case–control study design. Cases were all subjects including children with any fracture sustained during the year 2000 (n = 124,655). For each case, three controls (n = 373,962) matched according to age and gender was randomly drawn from the background population. Adjustments were made for use of other psychotropic drugs (neuroleptics, antidepressants, and anxiolytics/sedatives), psychiatric disease (manic depressive states, schizophrenia, and other psychoses), and other confounders. The effect of dose was examined by stratifying for cumulated dose (DDD, defined daily dose). In the crude analysis, there was a decreasing relative risk of any fracture with increasing accumulated dose of lithium. After adjustment for psychotropic drug use, the risk of any fracture was decreased (odds ratio [OR] 0.74, 95% confidence interval [CI] 0.60–0.92 for 250–849 DDD, and OR 0.67, 95% CI 0.55–0.81 for ≥ 850 DDD of lithium). For Colles’ fractures and spine fractures, a significant decrease was seen with ≥ 850 DDD (OR 0.57, 95% CI 0.35–0.94 for Colles’ fracture and OR 0.32, 95% CI 0.11–0.95 for spine fractures). For hip fractures, a nonsignificant trend toward a decrease was seen; however, without a dose-response relationship. Adjustment for further confounders did not change the results. Lithium treatment was associated with a decreased risk of fractures potentially pointing at bone anabolic properties.


Fracture Lithium Epidemiology Risk 


  1. 1.
    Baastrup, PC, Christiansen, C, Transbol, I 1978Calcium metabolism in lithium-treated patients. Relation to uni-bipolar dichotomyActa Psychiatr Scand57124128PubMedGoogle Scholar
  2. 2.
    Christiansen, C, Baastrup, PC, Transbol, I 1977Lithium-induced “primary” hyperparathyroidismCalcif Tissue Res22341343CrossRefPubMedGoogle Scholar
  3. 3.
    Christiansen, C, Baastrup, PC, Transbol, I 1975Osteopenia and dysregulation of divalent cations in lithium-treated patientsNeuropsychobiology1344354PubMedGoogle Scholar
  4. 4.
    Eren, Y, Yyldyz, M, Civi, Y, Gundodar, D, Ozcankaya, R 2003The effects of lithium treatment on bone mineral density of bipolar patientsEur Neuropsychopharmacol13S249Google Scholar
  5. 5.
    Christiansen, C, Baastrup, PC, Transbol, I 1980Development of ‘primary’ hyperparathyroidism during lithium therapy: longitudinal studyNeuropsychobiology6280283PubMedGoogle Scholar
  6. 6.
    Christiansen C, Baastrup PC, Transbol I (1976) Lithium, hypercalcemia, hypermagnesemia, and hyperparathyroidism Lancet 2:969CrossRefPubMedGoogle Scholar
  7. 7.
    Stancer, HC, Forbarh, N 1989Hyperparathyroidism, hypothyroidism, and impaired renal function after 10 to 20 years of lithium treatmentArch Intern Med14910421045CrossRefPubMedGoogle Scholar
  8. 8.
    Cohen, O, Rais, T, Lepkifker, E, Vered, I 1998Lithium carbonate therapy is not a risk factor for osteoporosisHorm Metab Res30594597PubMedGoogle Scholar
  9. 9.
    Nordenstrom, J, Elvius, M, Bagedahl-Strindlund, M, Zhao, B, Torring, O 1994Biochemical hyperparathyroidism and bone-mineral status in patients treated long-term with lithiumMetabolism4315631567CrossRefPubMedGoogle Scholar
  10. 10.
    Boer, J, Wang, HJ, Blitterswijk, C 2004Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cellsTissue Eng10393401CrossRefPubMedGoogle Scholar
  11. 11.
    Pepersack, T, Corvilain, J, Bergmann, P 1994Effects of lithium on bone resorption in cultured foetal rat long-bonesEur J Clin Invest24400405PubMedGoogle Scholar
  12. 12.
    Seely, EW, Moore, TJ, Leboff, MS, Brown, EM 1989A single dose of lithium carbonate acutely elevates intact parathyroid hormone levels in humansActa Endocrinol (Copenh)121174176Google Scholar
  13. 13.
    Ray, WA, Griffin, MR, Schaffner, W, Baugh, DK, Melton, LJ,III 1987Psychotropic drug use and the risk of hip fractureN Engl J Med316363369PubMedGoogle Scholar
  14. 14.
    Chan, S, Lambert, L, Cauley, J, Ensrud, K, Orwoll, E, Bliziotes, M 2004SSRI use is associated with lower BMD among menJ Bone Mineral Res19S7Google Scholar
  15. 15.
    Ensrud, KE, Blackwell, T, Mangione, CM, Bowman, PJ, Bauer, DC, Schwartz, A, Hanlon, JT, Nevitt, MC, Whooley, MA 2003Central nervous system active medications and risk for fractures in older womenArch Intern Med163949957CrossRefPubMedGoogle Scholar
  16. 16.
    Hubbard, R, Farrington, P, Smith, C, Smeeth, L, Tattersfield, A 2003Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fractureAm J Epidemiol1587784CrossRefPubMedGoogle Scholar
  17. 17.
    Wang, PS, Bohn, RL, Glynn, RJ, Mogun, H, Avorn, J 2001Zolpidem use and hip fractures in older peopleJ Am Geriatr Soc4916851690CrossRefPubMedGoogle Scholar
  18. 18.
    Wang, PS, Bohn, RL, Glynn, RJ, Mogun, H, Avorn, J 2001Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fractureAm J Psychiatry158892898PubMedGoogle Scholar
  19. 19.
    Herings, RM, Stricker, BH, Boer, A, Bakker, A, Sturmans, F 1995Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-lifeArch Intern Med15518011807CrossRefPubMedGoogle Scholar
  20. 20.
    Wong, SY, Lau, EM, Lynn, H, Leung, PC, Woo, J, Cummings, SR, Orwoll, E 2005Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong)Osteoporos Int16610615CrossRefPubMedGoogle Scholar
  21. 21.
    Yazici, KM, Akinci, A, Sutcu, A, Ozcakar, L 2003Bone mineral density in premenopausal women with major depressive disorderPsychiatry Res117271275CrossRefPubMedGoogle Scholar
  22. 22.
    Jones, S, Johansen, A, Brennan, J, Butler, J, Lyons, RA 2004The effect of socioeconomic deprivation on fracture incidence in the United KingdomOsteoporosis Int15520524CrossRefGoogle Scholar
  23. 23.
    Vestergaard, P, Emborg, C, Støving, RK, Hagen, C, Mosekilde, L, Brixen, K 2002Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—a nation-wide register studyInt J Eating Disord32301308CrossRefGoogle Scholar
  24. 24.
    Klotzbuecher, CM, Ross, PD, Landsman, PB, Abbott, III TA, Berger, M 2000Patients with prior fractures have an increased risk of future fractures: a summary of the litterature and statistical synthesisJ Bone Miner Res15721739PubMedGoogle Scholar
  25. 25.
    Staa, TP, Leufkens, HGM, Abenhaim, L, Zhang, B, Cooper, C 2000Use of oral corticosteroids and risk of fracturesJ Bone Mineral Res159931000Google Scholar
  26. 26.
    Vestergaard, P, Rejnmark, L, Mosekilde, L 2004Fracture risk associated with use of anti-epileptic drugsEpilepsia4513301337CrossRefPubMedGoogle Scholar
  27. 27.
    Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR 1987A method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chron Dis40373383CrossRefPubMedGoogle Scholar
  28. 28.
    Andersen, TF, Madsen, M, Jørgensen, J, Mellemkjær, L, Olsen, JH 1999The Danish National Hospital RegisterDan Med Bull46263268PubMedGoogle Scholar
  29. 29.
    Munk-Jørgensen, P, Mortensen, PB 1997The Danish Psychiatric Central RegisterDan Med Bull448284PubMedGoogle Scholar
  30. 30.
    Mosbech, J, Jørgensen, J, Madsen, M, Rostgaard, K, Thornberg, K, Poulsen, TD 1995[The Danish National Patient Register: evaluation of data quality]Ugeskr læger15737413745PubMedGoogle Scholar
  31. 31.
    Vestergaard, P, Mosekilde, L 2002Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in DenmarkAm J Epidemiol156110CrossRefPubMedGoogle Scholar
  32. 32.
    Pepersack, T, Corazza, F, Demulder, A, Guns, M, Fondu, P, Bergmann, P 1994Lithium inhibits calcitriol-stimulated formation of multinucleated cells in human long-term marrow culturesJ Bone Miner Res9645650PubMedGoogle Scholar
  33. 33.
    Brown, EM 1981Lithium induces abnormal calcium-regulated PTH release in dispersed bovine parathyroid cellsJ Clin Endocrinol Metab5210461048PubMedGoogle Scholar
  34. 34.
    Neer, RM, Arnaud, CD, Zanchetta, JR, Prince, RL, Gaich, GA, Reginster, J-Y, Hodsman, AB, Eriksen, EF, Ish-Shalom, S, Genant, HK, Wang, O, Mitlak, BH 2001Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosisN Engl J Med34414341441CrossRefPubMedGoogle Scholar
  35. 35.
    Mak, TWL, Shek, CC, Chow, CC, Wing, YK, Lee, S 1998Effects of lithium therapy on bone mineral metabolism: A two-year prospective longitudinal studyJ Clin Endocrinl Metab8338573859CrossRefGoogle Scholar
  36. 36.
    Black, DM, Cummings, SR, Kerpf, DB, Cauley, J, Thompson, DE, Nevitt, MC, Bauer, DC, Genant, HK, Haskell, WL, Marcus, R, Ott, SM, Torner, JC, Quandt, SA, Reiss, TF, Ensrud, KE 1996Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fracturesLancet34815351541CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  1. 1.Department of Endocrinology and Metabolism CAarhus University HospitalAarhus SygehusDenmark

Personalised recommendations